Form 4/A for NVCT Nuvectis Pharma, Inc.
Accepted 2024-12-16 00:00:00 ET · period of report 2024-12-12 · accession 0001104659-24-129009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2024-12-16 | 2024-12-12+ | NVCT | Mosseri Marlio Charles | 10% | P - Purchase | $4.66 | +49.1K | 2.63M | +2% | +$228.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-13 | P | A | 17,000 | $4.70 | 2,644,121 | D | — | — | (F1) The original Form 4, filed on December 16, 2024, is being amended by this Form 4 amendment to include a transaction that occurred on December 12, 2024, and to correct the amount of securities beneficially owned by the reporting person as a result of the reported transactions. |
| 2 | Common | Common Stock | 2024-12-12 | P | A | 32,121 | $4.64 | 2,627,121 | D | — | — |